Edwards Lifesciences Corporation (EW) Q4 2015 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Down 2.45%

Edwards Lifesciences reported a better-than-expected EPS, which indicates strong profitability. However, the stock fell by 2.45%, likely due to the absence of revenue data and guidance. Investors may be concerned about future growth without clearer direction from management.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.63	N/A	+6.42%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's future. They emphasized their commitment to innovation and growth.

Management expressed satisfaction with EPS performance despite lack of revenue guidance.

They highlighted ongoing investments in product development as a priority.

Edwards Lifesciences Beats on EPS, Stock Down 2.45%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Down 2.45%

Key numbers

Management commentary